Translational Development Acquisition earnings were -$71.0k for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest TDAC earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$8.0k, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TDAC reported annual earnings of -$71.0k, with -85.4% growth.
TDAC earnings history
Current Revenue
$0.0
Current Earnings
-$71.0k
Current Profit Margin
0%
TDAC Return on Equity
Insufficient data to display
TDAC undefined
Current Company
-0.1%
Current Industry
-0.8%
Be the first to know when TDAC announces earnings.
Translational Development Acquisition Earnings Reports & History FAQ
What were Translational Development Acquisition's earnings last quarter?
Translational Development Acquisition (NASDAQ: TDAC) reported Q4 2024 earnings per share (EPS) of $0.00, up 100% year over year. Total TDAC earnings for the quarter were -$8.04 thousand. In the same quarter last year, Translational Development Acquisition's earnings per share (EPS) was -$0.12.
Is Translational Development Acquisition profitable or losing money?
As of the last Translational Development Acquisition earnings report, Translational Development Acquisition is currently losing money. Translational Development Acquisition's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$71.01 thousand, a 85.37% decrease year over year.
What was TDAC's earnings growth in the past year?
As of Translational Development Acquisition's earnings date in Q2 2025, Translational Development Acquisition's earnings has grown year over year. TDAC earnings in the past year totalled -$71.01 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.